Financials
- Market Capitalization 19.29 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.42
Rapporto prezzo/fatturato
207.27
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4624 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.26 USD | -5.83% | -9.96% | -4.24% | +148.35% | 19.46 M USD | ||
| 4625 | LGVN Longeveron Inc. - Class A Common stock | 0.62 USD | -1.59% | -3.13% | -21.52% | +8.52% | 19.31 M USD | ||
| 4628 | ICU SeaStar Medical Holding Corporation - Common Stock | 4.80 USD | +0.21% | -3.23% | +54.84% | +95.12% | 19.19 M USD | ||
| 4630 | NCEL NewcelX Ltd. - Ordinary Shares | 3.98 USD | -0.50% | +0.51% | +24.37% | -21.65% | 19.09 M USD |